HC Wainwright & Co. Reiterates Buy on Renalytix, Maintains $5 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Renalytix (NASDAQ:RNLX) and maintained a $5 price target.
June 30, 2023 | 10:16 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Renalytix's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $5.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. The maintained price target of $5 indicates the firm's confidence in the stock's potential to reach this price. This could lead to increased investor confidence and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100